William Krimsky

Dr. Krimsky is Director and Chief of Interventional Pulmonary Medicine at MedStar Franklin Square Medical Center. He has made a significant commitment to the invention, development, and design of supportive devices for pulmonary and critical care patients who are often without viable treatment options. Dr. Krimsky is an inventor on 16 published patents, 14 of which have been licensed or purchased by industry, and another 12 patents that are as yet unpublished. Dr. Krimsky was involved in each step, from concept to market, in the development of CSA Medical’s spray cryotherapy truFreeze® system. Dr. Krimsky has served as a site PI, along with other national thought leaders, on several seminal pulmonary technology trials including the Rox Medical WALK trial, the PneumRx RENEW trial, and the Broncus Technologies EASE trial. As a member of the American College of Chest Physicians, Dr. Krimsky has participated in lobbying the AMA/Specialty Society Relative Value Scale Update Committee (RUC) for CPT codes for procedures ranging from endobronchial ultrasound, navigational bronchoscopy, and endobronchial valves. Dr. Krimsky and his team have worked to incorporate a variety of different medical and surgical specialties in the care of patients with advanced lung disease in an effort to provide integrated, cost-effective care. Dr. Krimsky is a graduate of Middlebury College, University of Pittsburgh School of Medicine, Johns Hopkins University/Sinai Hospital Program in Internal Medicine (where he served as Chief Resident), and the Dartmouth-Hitchcock Medical Center pulmonary medicine and critical care medicine fellowship training program.